Revelation Biosciences, Inc.
Pharmaceutical Preparations · San Diego, CA, United States
- PrincipalsChester Stanley Zygmont IIIChief Financial OfficerJames RolkeChief Executive Officerand 3 more
- CompanyRevelation Biosciences, Inc.San Diego, CA, United States
- Phone line+1 (650) 800-3717General business
Revelation Biosciences, Inc. is an SEC-registered Nasdaq-listed company (ticker REVB) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 5
Chief executive
James RolkeChief Executive Officer
Chair & board
Jennifer CarverDirector (Board)
Jess RoperDirector (Board)
Lakhmir S ChawlaDirector (Board)
Finance
Chester Stanley Zygmont IIIChief Financial Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Chester Stanley Zygmont III — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗James Rolke — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Jennifer Carver — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Jess Roper — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Roivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capability